Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy
暂无分享,去创建一个
Detcho A. Stoyanovsky | Jianfei Jiang | Valerian E. Kagan | V. Kagan | A. Mintz | Jianfei Jiang | N. Belikova | Zhentai Huang | Natalia A. Belikova | Arlan H. Mintz | D. Stoyanovsky | Zhen-tai Huang
[1] D P Byar,et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.
[2] D. Schoenfeld,et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.
[3] S. Hahn,et al. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. , 1991, Archives of biochemistry and biophysics.
[4] S. Hahn,et al. Identification of nitroxide radioprotectors. , 1992, Radiation research.
[5] S. Hahn,et al. Tempol, a stable free radical, is a novel murine radiation protector. , 1992, Cancer research.
[6] C C Ling,et al. Radiation-induced apoptosis: relevance to radiotherapy. , 1995, International journal of radiation oncology, biology, physics.
[7] R. Burdon. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. , 1995, Free radical biology & medicine.
[8] B. Dutrillaux,et al. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. , 1997, Anticancer research.
[9] M. Murphy,et al. Selective targeting of bioactive compounds to mitochondria. , 1997, Trends in biotechnology.
[10] S. Hahn,et al. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. , 1998, International journal of radiation oncology, biology, physics.
[11] A. Haimovitz-Friedman,et al. Nitroxides Tempol and Tempo Induce Divergent Signal Transduction Pathways in MDA-MB 231 Breast Cancer Cells* , 1998, The Journal of Biological Chemistry.
[12] S. Hahn,et al. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. , 2000, Free radical biology & medicine.
[13] James B. Mitchell,et al. Nitroxides as radiation protectors. , 2002, Military medicine.
[14] E. Monti,et al. Study of in vitro and in vivo effects of the piperidine nitroxide Tempol--a potential new therapeutic agent for gliomas. , 2003, European journal of cancer.
[15] James B. Mitchell,et al. Factors influencing nitroxide reduction and cytotoxicity in vitro. , 2004, Antioxidants & redox signaling.
[16] E. Azzam,et al. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology , 2004, Cancer and Metastasis Reviews.
[17] P. Wipf,et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. , 2005, Journal of the American Chemical Society.
[18] V. Kavsan,et al. Reduction of the transcription level of the mitochondrial genome in human glioblastoma. , 2005, Cancer letters.
[19] Qing Zhao,et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors , 2005, Nature chemical biology.
[20] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[21] James B. Mitchell,et al. Therapeutic and clinical applications of nitroxide compounds. , 2007, Antioxidants & redox signaling.
[22] P. Wipf,et al. Structural Requirements for Optimized Delivery, Inhibition of Oxidative Stress, and Antiapoptotic Activity of Targeted Nitroxides , 2007, Journal of Pharmacology and Experimental Therapeutics.
[23] Stephen L. Brown,et al. Mechanisms of radiation-induced brain toxicity and implications for future clinical trials , 2008, Journal of Neuro-Oncology.
[24] Qing Zhao,et al. A Mitochondria-Targeted Triphenylphosphonium-Conjugated Nitroxide Functions as a Radioprotector/Mitigator , 2009, Radiation research.
[25] James B. Mitchell,et al. Radioprotectors and Mitigators of Radiation-Induced Normal Tissue Injury , 2010, The oncologist.